FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation-Reference-Cited by-同舟云学术

FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation

Published:2019-02-13 Issue:5 Volume:276 Page:1447-1455
ISSN:0937-4477
Container-title:European Archives of Oto-Rhino-Laryngology
language:en
Short-container-title:Eur Arch Otorhinolaryngol

Author:

de Ridder Mischa,Gouw Zeno A. R.,Navran Arash,Hamming-Vrieze Olga,Jasperse Bas,van den Brekel Michiel W. M.,Vogel Wouter V.,Al-Mamgani A.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Otorhinolaryngology

Link

http://link.springer.com/article/10.1007/s00405-019-05340-9/fulltext.html

Reference22 articles.

1. Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949–955

2. Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92(1):4–14. https://doi.org/10.1016/j.radonc.2009.04.014

3. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578. https://doi.org/10.1056/NEJMoa053422

4. de Ridder M, Gouw ZAR, Sonke JJ, Navran A, Jasperse B, Heukelom J, Tesselaar MET, Klop WMC, van den Brekel MWM, Al-Mamgani A (2017) Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival. Eur Arch Otorhinolaryngol 274(3):1691–1700. https://doi.org/10.1007/s00405-016-4413-7

5. Mehanna H, Wong WL, McConkey CC, Rahman JK, Robinson M, Hartley AG, Nutting C, Powell N, Al-Booz H, Robinson M, Junor E, Rizwanullah M, von Zeidler SV, Wieshmann H, Hulme C, Smith AF, Hall P, Dunn J, Group P-NTM (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374(15):1444–1454. https://doi.org/10.1056/NEJMoa1514493

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline;Practical Radiation Oncology;2024-09

2. The Role of Biomarkers in HPV-Positive Head and Neck Squamous Cell Carcinoma: Towards Precision Medicine;Diagnostics;2024-07-07

3. Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition;The Journal of Laryngology & Otology;2024-03-14

4. Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review;Current Oncology Reports;2023-03-07

5. HPV DNA as a Biomarker in Oropharyngeal Cancer: A Step in the Right Direction;Clinical Cancer Research;2022-07-21